Recombinant Human IGFBP5 | Z102015

abm | Recombinant Human IGFBP5 | Z102015

An IGF-binding protein, IBP-5 is produced by fibroblasts, myoblasts, osteoblasts and vascular smooth muscle cells. IBP-5 has been shown to specifically inhibit breast cancer cell growth by inducing apoptosis. IBP-5 contains an IGFBP domain and a thyroglobulin type-1 domain.

Functions:

N.A.

Organism:

Human

Source:

E. coli

Alias:

IBP-5, IGF-binding protein 5, IGFBP-5, IGF-BP5
Recombinant Human Insulin-Like Growth Factor Binding Protein 5 (IGFBP5)

Gene Symbol:

IGFBP5

Gene ID:

3488

Accession:

P24593

Formulation:

Lyophilized from a 0.2 μm filtered solution of 10mM sodium Citrate pH 3.0

Solubility:

A quick spin of the vial followed by reconstitution in sterile distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

Appearance:

Lyophilized Powder

Molecular Weight (kDa):

26,5

Molecular Weight 2 (kDA):

N/A

Molecular Weight 3 (kDA):

N/A

Purity:

>95% as determined by SDS-PAGE

Concentration:

<1.0 EU/μg of recombinant protein as determined by the LAL method.

Shipping Condition :

Ambient Temperature

Storage Condition:

The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.